Home › Calculator › IOBCF Dividend Calculator 2026
IOBCF Dividend DRIP Calculator 2026
1.52% YieldHealthcareIon Beam Applications S.A. · OTC
Price: $19.10 · Annual div: $0.29/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When IOBCF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your IOBCF snowball 📈
$10,000 in IOBCF → $11.58M in 10 years · $14,891.91/month
About Ion Beam Applications S.A. (IOBCF) — Dividend Analysis 2026
Ion Beam Applications S.A. (IBA) is a company specializing in the design, manufacturing, and ongoing support of sophisticated medical equipment and software solutions primarily focused on treating cancer. Its operations span Belgium, the United States, and various international markets. The company's activities are broadly organized into two main divisions: 1. Proton Therapy and Other Accelerators: This segment is responsible for the engineering, construction, and maintenance of both medical and industrial particle accelerators, including complete proton therapy systems. It also delivers comprehensive, ready-to-use systems for cancer treatment leveraging proton beams. Furthermore, this division produces a variety of cyclotron machines for generating radioisotopes vital for Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) imaging, alongside industrial-grade accelerators used in sterilization and ionization processes. 2. Dosimetry: This division offers specialized tools and expert services aimed at enhancing the precision and minimizing errors in radiation oncology treatments, as well as in the quality assurance and calibration protocols for medical imaging systems. IBA actively engages in strategic collaborations, including a key research and development partnership with SCK CEN (the Belgian nuclear research center) focused on enabling the synthesis of Actinium-225 (225Ac), a pioneering radioisotope for cancer therapy. The company also collaborates with the University of Pennsylvania for cutting-edge research into ConformalFLASH technology. Ion Beam Applications S.A. was established in 1986 and maintains its corporate headquarters in Louvain-la-Neuve, Belgium.
Compare IOBCF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full IOBCF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IOBCF position with:
🌍 IOBCF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold IOBCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.52% | -1.28% | $152 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.29% | -1.51% | $129 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.22% | -1.58% | $122 / yr |
| 🇬🇧 UK ISA | 0% | 1.52% | -1.28% | $152 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.39% | -1.41% | $139 / yr |
| 🇨🇦 TFSA | 0% | 1.52% | -1.28% | $152 / yr |
| 🇨🇦 CA Taxable | 25% | 1.14% | -1.66% | $114 / yr |
| 🇦🇺 Super (pension) | 15% | 1.29% | -1.51% | $129 / yr |
| 🇦🇺 AU Taxable | 30% | 1.06% | -1.74% | $106 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.12% | -1.68% | $112 / yr |
| 🇫🇷 FR Taxable | 30% | 1.06% | -1.74% | $106 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 IOBCF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.29/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 IOBCF Dividend Payment Schedule
IOBCF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 IOBCF vs Healthcare Benchmarks
How IOBCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IOBCF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ IOBCF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IOBCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Ion Beam Applications S.A. (IOBCF) is currently trading at $19.10, 18% below its 52-week high. The current dividend yield is 1.52% based on an annual payout of $0.29 per share.
IOBCF (Ion Beam Applications S.A.) — 1.52% Dividend Yield Analysis
Ion Beam Applications S.A. (IOBCF) is a healthcare stock currently trading at $19.10 with a dividend yield of 1.52%. The company pays an annual dividend of $0.29 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, IOBCF has grown its dividend at a compound annual rate of 100.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.